Analysed WORK MEDICAL TECHNOLOGY GR-A (WOK:NASDAQ) News Sources
WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026
29-12-2025
yahoo.com
WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer
29-12-2025
yahoo.com
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025
24-12-2025
yahoo.com
WORK Medical Technology Group LTD’s Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation
04-11-2025
yahoo.com
WORK Medical Technology Group LTD Announces US$1 Million Equity Investment in Neologics Bioscience
21-10-2025
yahoo.com
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025
16-10-2025
yahoo.com
WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq
14-10-2025
yahoo.com
WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance
10-10-2025
yahoo.com
What is the current price of WORK MEDICAL TECHNOLOGY GR-A (WOK:NASDAQ)?
The current price of WORK MEDICAL TECHNOLOGY GR-A (WOK:NASDAQ) is $1.22.
WORK MEDICAL TECHNOLOGY GR-A (WOK:NASDAQ) absolute price change since previous trading day?
The absolute price change of WORK MEDICAL TECHNOLOGY GR-A (WOK:NASDAQ) since the previous trading day is $0.05.
WORK MEDICAL TECHNOLOGY GR-A (WOK:NASDAQ) percentage price change since previous trading day?
The percentage price change of WORK MEDICAL TECHNOLOGY GR-A (WOK:NASDAQ) since the previous trading day is 4.2735%.
What is the most recent average sentiment score for WORK MEDICAL TECHNOLOGY GR-A (WOK:NASDAQ)?
The most recent average sentiment score for WORK MEDICAL TECHNOLOGY GR-A (WOK:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for WORK MEDICAL TECHNOLOGY GR-A (WOK:NASDAQ)?
The most recent sentiment for WORK MEDICAL TECHNOLOGY GR-A (WOK:NASDAQ) is .
SEC-8K** Filing Available For WORK MEDICAL TECHNOLOGY GR-A (WOK:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.